Search for: "NOVARTIS CONSUMER HEALTH, INC." Results 1 - 20 of 77
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Jan 2012, 11:06 am
Novartis Consumer Health, Inc. recently announced the voluntary recall of select bottles of Excedrin, NoDoz, Bufferin and Gas-X. [read post]
10 Jan 2012, 11:06 am
Novartis Consumer Health, Inc. recently announced the voluntary recall of select bottles of Excedrin, NoDoz, Bufferin and Gas-X. [read post]
28 Jan 2016, 2:19 pm by Phyllis H. Marcus and Emma Lewis
On January 27, 2016, the National Advertising Review Board (“NARB”) went after dietary supplements, recommending that Novartis Consumer Health, Inc. [read post]
10 Jan 2012, 3:22 pm by info@thomasjhenrylaw.com
Novartis Consumer Health, Inc. has issued a recall on several popular over-the-counter medications including Excedrin, NoDoz, Bufferin, and Gas-X due to a possible manufacturing mix-up. [read post]
11 Jan 2012, 8:39 am by Peter N. Freiberg
Novartis Consumer Health, Inc. announced on January 8, 2012 that it was voluntarily recalling all lots of select bottle packaging configurations of Excedrin and NoDoz with expiration dates of December 20, 2014 or earlier, as well as Bufferin and Gas-X prevention products with expiration dates of December 20, 2013 or earlier. [read post]
11 Dec 2009, 11:13 am by Tom Lamb
This December 2009 FDA MedWatch alert also provided links to:  (1) "Prescribing Information" -- also known as the package insert or label -- for Voltaren Gel; and, (2)  a "Dear Healthcare Professional Letter" -- commonly called a "Dear Doctor" letter -- from Endo Pharmaceuticals Inc. and Novartis Consumer Health, Inc., the companies responsible for Voltaren Gel in the U.S. [read post]
21 Sep 2020, 12:41 pm by Rebecca Tushnet
Finally, Diamond tried to get the court to adopt the rule of Novartis Consumer Health, Inc. v. [read post]
18 Jul 2011, 6:12 am by Rebecca Tushnet
Precision argued that PCM couldn’t “salvage wholly unsubstantiated statements with arguments cobbled together after the statements were made,” citing Novartis Consumer Health, Inc. v. [read post]
1 Dec 2011, 3:58 am by Lawrence B. Ebert
Bloomberg also reported: Pfizer has struck deals with companies including Catalyst Health Solutions Inc. and Coventry Health Care Inc. to prevent generic Lipitor from reaching some patients until the end of May 2012. [read post]
1 Jun 2010, 2:04 pm by The Docket Navigator
Novartis Animal Health US, Inc., 1-10-cv-01267 (ILND)Amended Complaint filed April 27, 2010.The plaintiff following Mr. [read post]
10 Feb 2013, 4:00 pm by Amber Walsh
FDA held discussions mid-December about the regulatory landscape of compounding drugs with more than 50 groups, including pharmacies, consumers, hospitals, clinics and medical professionals. [read post]
22 Apr 2013, 5:34 am by Rebecca Tushnet
  While a completely unsubstantiated ad claim is literally false without further affirmative evidence from the plaintiff, Novartis Consumer Health, Inc. v. [read post]
13 Apr 2011, 2:29 pm by Rebecca Tushnet
’” Guidance didn’t do any testing, therefore this (implicit) claim was false because it was utterly unsubstantiated (citing Novartis Consumer Health, Inc. v. [read post]
12 Mar 2012, 5:41 pm by FDABlog HPM
Novartis Pharmaceuticals Corp., No. 33-av-00001 (D.N.J., Mar. 7, 2012) (Complaint) Plumbers and Pipefitters Local 572 Health and Welfare Fund v. [read post]